Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease

Utilization of the adaptive immune system against malignancies, both by immune-based therapies to activate T cells in vivo to attack cancer and by T-cell therapies to transfer effector cytolytic T lymphocytes (CTL) to the cancer patient, represent major novel therapeutic advancements in oncologic th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tijaro-Ovalle, Natalia M., Karantanos, Theodoros, Wang, Hong-Tao, Boussiotis, Vassiliki A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411635/
https://www.ncbi.nlm.nih.gov/pubmed/30891031
http://dx.doi.org/10.3389/fimmu.2019.00295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411635/
https://www.ncbi.nlm.nih.gov/pubmed/30891031
http://dx.doi.org/10.3389/fimmu.2019.00295

Ejemplares similares